Nascent Biotech, Inc. reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was USD 1 million compared to USD 0.75 million a year ago. Net loss was USD 0.47039 million compared to USD 0.958767 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | +3.46% | +12.64% | -47.95% |
1st Jan change | Capi. | |
---|---|---|
-47.95% | 14.84M | |
+16.42% | 124B | |
+19.02% | 112B | |
+3.52% | 22.94B | |
-11.63% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+2.68% | 13.63B | |
+21.16% | 11.61B | |
+108.78% | 10.31B |
- Stock Market
- Equities
- NBIO Stock
- News Nascent Biotech, Inc.
- Nascent Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022